Leerink Partners Downgrades Regeneron Pharma (REGN) to Market Perform, 'Eylea Franchise Outlook Uncertain'
Tweet Send to a Friend
(Updated - September 24, 2024 9:44 AM EDT)
Leerink Partners analyst Andrew Berens downgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst Andrew Berens downgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
